Melanovus Oncology Inc is categorized under Commercial Biotechnical Research in Jensen Beach, FL and active since 2012.
Melanovus Oncology Inc was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Thomas Lytle at the company’s single location by writing to 2301 Ne Savannah Road # 528, Jensen Beach, Florida FL 34958 or by phoning (772) 245-6352. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Melanovus Oncology Inc |
| Contact Person: | Thomas Lytle |
| Address: | 2301 Ne Savannah Road # 528, Jensen Beach, Florida 34958 |
| Phone Number: | (772) 245-6352 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Melanovus Oncology Inc was started in 2012 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Thomas Lytle for inquiries that concern Melanovus Oncology Inc by calling the company number (772) 245-6352, as your correspondence is most welcome. Additionally, the physical location of the single location of Melanovus Oncology Inc can be found at the coordinates 27.23411,-80.23619 as well as the street address 2301 Ne Savannah Road # 528 in Jensen Beach, Florida 34958.
For its online presence, you may visit Melanovus Oncology Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.